Fig. 5From: The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysisIncremental cost-effectiveness plane for the case base. Current Scr. Current first- and second-trimester screening, ICER Incremental cost-effectivenes, NIPT-ct DNA-based non-invasive prenatal testing as contingent testing, NIPT-flt DNA-based non-invasive prenatal testing as first-line testingBack to article page